About the ACS IRG
The American Cancer Society Institutional Research Grants (ACS IRG) is awarded to early-stage investigators to pursue basic, pre-clinical, clinical and cancer-control research studies. These funds are intended for new investigators who are within six years of their first academic appointment, and to provide new investigators with necessary resources to more rapidly develop their research, generate pilot data and publish their results, all of which enhances their ability to compete for national-level funding.
Award details
- Awards of up to $50,000/year are provided for up to three early-stage investigators each year
- Awardees must have an established mentor/mentoring team in place
- A Massey investigator may only hold one active pilot research award at a time
Application requirements
- Applicants are required to consult with a biostatistician as part of the proposal to assist with design and statistical methods if applicable. For biostatistical support, please contact Massey's Biostatistics Shared Resource.
- Applicants are also encouraged to engage a Community Champion in the project. Please contact cancerchamps@vcu.edu to set an appointment for your consultation.
Upcoming deadlines and award dates
2026 (cycle 2) applications are now being accepted! Please find the details for the application process below:
- Notice of Funding Opportunity (NOFO) will be available on October 15, 2025
- Letter of intents are due by December 1, 2025
- Full applications due by January 15, 2026 at 5:00 p.m. (EST).
Application Materials
If you have questions about the ACS IRG, please contact Alex Haynes at haynesa4@vcu.edu or Cian Myers at myersc4@vcu.
Previous ACS IRG awardees
| Awardees | Project |
|---|---|
|
Ruchi Desai, MD |
Characterization of Cell-Cell Interactions within the Bone Marrow Microenvironment of Patients with Myelofibrosis Utilizing Spatial Transcriptomics |
| Alexander Kenigsberg, MD Assistant Professor, Urology |
Evaluation of Raman Spectroscopy Artificial Intelligence Tool for Urine-Based Detection of Prostate Cancer |
| Quang Le, Ph.D. Assistant Professor, Rheumatology, Allergy and Immunology |
Impact of the Human α/β-tryptase Heterotetramers in the Progression of Adenocarcinoma Type Non-Small Cell Lung Cancer (A-NSCLC): Clinical Implications and Future Applications |
| Awardees | Project |
|---|---|
|
Wendy J. Bottinor, MD |
Treating Maladaptive Cardiac Fibrosis and Preventing Symptomatic Heart Failure Among C-AYA Cancer Survivors |
| Sarah Braun, Ph.D. Assistant Professor, Neurology |
C-SMART for Patients with Primary Brain Tumors: A Feasibility and Acceptability Pilot of a Novel Neuropsychological Rehabilitation Intervention and Neurobiological Research Procedures |
| Adam Khader, M.D., Ph.D. Assistant Professor, Surgery |
Role of FXIIIa in Colorectal Cancer Peritoneal Metastasis |
| Emily Kinsey, M.D. Assistant Professor, Internal Medicine |
A Pilot Study to Evaluate the Efficacy and Safety of the Addition of Ciprofloxacin, Metronidazole and Aspirin in Addition to Chemotherapy in Patients Undergoing First Line Therapy for Metastatic Colorectal Cancer |
| Carrie Miller, Ph.D., M.P.H. Assistant Professor, Family Medicine & Population Health |
Enhancing Access to Multicenter Early Detection Trials |
|
Katarzyna M. Tyc, PhD |
Building Cancer Pangenomes to Eliminate Biomarker Disparities |
| Awardees | Project |
|---|---|
| Elizabeth Krieger, M.D. Assistant Professor, Pediatrics |
Understanding Donor Lymphocyte Infusion Response |
| Jiong Li, Ph.D. Assistant Professor, Medicinal Chemistry |
KDM5 is a Novel Therapeutic Target for Colorectal Cancer |
| Autumn Lanoye, Ph.D. Assistant Professor, Internal Medicine |
Feasibility and Acceptability of an Anti-Inflammatory Lifestyle Intervention for Emerging Adult Cancer Survivors |
| Lathika Mohanraj, Ph.D. Assistant Professor, Adult Health & Nursing Systems |
Investigation of Psychosocial Biomarkers and Transplant Outcomes in Hematopoietic Stem Cell Transplantation Recipients |
| Awardees | Project |
|---|---|
| Wook Jin (Eddie) Chae, Ph.D. Assistant Professor, Microbiology & Immunology |
Regulation of Innate Lymphoid Cell Mediated Anti-tumor Immunity by the Wnt System |
| Elizabeth Krieger, M.D. Assistant Professor, Pediatric Hematology & Oncology |
Understanding Donor Lymphocyte Infusion Response: A Longitudinal Molecular Examination of T-cell Receptor Diversity and Activation |
| Georgia Thomas, Ph.D. Assistant Professor, Internal Medicine |
Orthostatic Intolerance Syndromes Following Hematopoietic Stem Cell Transplantation |
| Katherine Tossas, Ph.D. Assistant Professor, Social & Behavioral Sciences |
Role of Varinal Microbiome on Human Papilloma Virus Carcinogenicity |
| Teresa Salgado, MPharm, Ph.D. Assistant Professor, Pharmacotherapy & Outcomes Science |
Preferences for Chemotherapy Discontinuation due to Chemotherapy Induced Peripheral Neuropathy Among Patients with Metastatic Breast Cancer |
| Awardees | Project |
|---|---|
| Richard "Inho" Joh, Ph.D. Assistant Professor, Physics |
Heterochromatin-mediated Mechanosensing for Tumor Dormancy |
| Jie Shen, Ph.D. Assistant Professor Epidemiology |
The Role of Allostatic Load and Biological Aging in the Association of Neighborhood Disadvantage with Breast Cancer Outcomes |
| Katherine Tossas, Ph.D. Assistant Professor, Social & Behavioral Sciences |
The Role of Allostatic Load and Biological Aging in the Association of Neighborhood Disadvantage with Breast Cancer Outcomes |
| Xuewei Wang, Ph.D. Assistant Professor, Chemistry |
Potassium Ionophore-based Lipid Nanoparticles for Treatment of Solid Tumors with Necrosis |
| Chunqing Guo, Ph.D. Assistant Professor, Cellular, Molecular and Genetic Medicine |
Blockade of Scavenger Receptor a to Enhance Cancer Immunotherapy and Radiotherapy |
| Rebecca Martin, Ph.D. Assistant Professor, Microbiology & Immunology |
ADAM17 and Membrane TNF on Macrophages Regulates ST2+ T Regulatory Cells that Limit Obesity-induced Inflammation in Mice |
| Sun Jung "Sunny" Kim, Ph.D. Assistant Professor, Social & Behavioral Sciences |
Cannabis Use and Acceptance among Cancer Survivors and Care Providers |